Clinical trial
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed…
NCT00416819 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00416819 |
|---|---|
| Title | Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma |
| Official title | Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: A Pilot Study |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Lymphoma |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, rituximab, cytarabine, etoposide phosphate, leucovorin calcium, methotrexate, temozolomide |
| Enrollment | 10 |
| Start date | Sep 1, 2003 |
| Primary completion | Dec 1, 2005 |
| Completion | Feb 1, 2012 |
| First posted | Dec 28, 2006 |
| Last update posted | Aug 20, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: